1. Home
  2. MRUS vs NMIH Comparison

MRUS vs NMIH Comparison

Compare MRUS & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • NMIH
  • Stock Information
  • Founded
  • MRUS 2003
  • NMIH 2011
  • Country
  • MRUS Netherlands
  • NMIH United States
  • Employees
  • MRUS N/A
  • NMIH N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • NMIH Property-Casualty Insurers
  • Sector
  • MRUS Health Care
  • NMIH Finance
  • Exchange
  • MRUS Nasdaq
  • NMIH Nasdaq
  • Market Cap
  • MRUS 2.7B
  • NMIH 2.8B
  • IPO Year
  • MRUS 2016
  • NMIH 2013
  • Fundamental
  • Price
  • MRUS $43.06
  • NMIH $33.68
  • Analyst Decision
  • MRUS Strong Buy
  • NMIH Buy
  • Analyst Count
  • MRUS 13
  • NMIH 7
  • Target Price
  • MRUS $86.85
  • NMIH $42.14
  • AVG Volume (30 Days)
  • MRUS 872.0K
  • NMIH 696.5K
  • Earning Date
  • MRUS 05-07-2025
  • NMIH 04-29-2025
  • Dividend Yield
  • MRUS N/A
  • NMIH N/A
  • EPS Growth
  • MRUS N/A
  • NMIH 15.37
  • EPS
  • MRUS N/A
  • NMIH 4.43
  • Revenue
  • MRUS $36,133,000.00
  • NMIH $650,971,000.00
  • Revenue This Year
  • MRUS $26.81
  • NMIH N/A
  • Revenue Next Year
  • MRUS $23.85
  • NMIH $5.25
  • P/E Ratio
  • MRUS N/A
  • NMIH $7.60
  • Revenue Growth
  • MRUS N/A
  • NMIH 12.43
  • 52 Week Low
  • MRUS $33.19
  • NMIH $29.05
  • 52 Week High
  • MRUS $61.61
  • NMIH $42.49
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 51.15
  • NMIH 42.74
  • Support Level
  • MRUS $33.19
  • NMIH $33.24
  • Resistance Level
  • MRUS $43.46
  • NMIH $34.95
  • Average True Range (ATR)
  • MRUS 3.53
  • NMIH 1.30
  • MACD
  • MRUS 0.34
  • NMIH -0.11
  • Stochastic Oscillator
  • MRUS 80.53
  • NMIH 34.70

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

Share on Social Networks: